← back to search

Johan Kuiper

Utrecht University · NL
Area of research
Immunology · Epidemiology
Research interest
Research interests include Medicine, Biology, Transcriptome, Immunology, Computational biology, and Macrophage.
h-index
citations
1,246
works
12
NIH funding
primary concept
email

Recent publications

Atherosclerotic Plaque Epigenetic Age Acceleration Predicts a Poor Prognosis and Is Associated With Endothelial-to-Mesenchymal Transition in Humans
Arteriosclerosis Thrombosis and Vascular Biology 2024cited by 17position: middledoi
Single-cell T cell receptor sequencing of paired human atherosclerotic plaques and blood reveals autoimmune-like features of expanded effector T cells
Nature Cardiovascular Research 2023cited by 83position: middledoi
Female Gene Networks Are Expressed in Myofibroblast-Like Smooth Muscle Cells in Vulnerable Atherosclerotic Plaques
Arteriosclerosis Thrombosis and Vascular Biology 2023cited by 30position: middledoi
Sex-specific differences in cytokine signaling pathways in circulating monocytes of cardiovascular disease patients
Atherosclerosis 2023cited by 17position: middledoi
Transcriptomic-based clustering of human atherosclerotic plaques identifies subgroups with different underlying biology and clinical presentation
Nature Cardiovascular Research 2022cited by 65position: middledoi
Intersecting single-cell transcriptomics and genome-wide association studies identifies crucial cell populations and candidate genes for atherosclerosis
European Heart Journal Open 2021cited by 75position: middledoi
Microanatomy of the Human Atherosclerotic Plaque by Single-Cell Transcriptomics
Circulation Research 2020cited by 565position: middledoi
Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis
Journal of the American College of Cardiology 2018cited by 194position: middledoi
Deficiency of the T cell regulator <i>Casitas B-cell lymphoma-B</i> aggravates atherosclerosis by inducing CD8+ T cell-mediated macrophage death
European Heart Journal 2018cited by 62position: middledoi
Leukocyte-Specific CCL3 Deficiency Inhibits Atherosclerotic Lesion Development by Affecting Neutrophil Accumulation
Arteriosclerosis Thrombosis and Vascular Biology 2013cited by 77position: middledoi
TLR Accessory Molecule RP105 (CD180) Is Involved in Post-Interventional Vascular Remodeling and Soluble RP105 Modulates Neointima Formation
PLoS ONE 2013cited by 34position: middledoi
Circulating cells as predictors of secondary manifestations of cardiovascular disease: design of the CIRCULATING CELLS study
Clinical Research in Cardiology 2013cited by 27position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Gerard Pasterkamp · Norwegian Womens Public Health Association7 papers (2013–2024)Menno P.J. de Winther · Amsterdam University Medical Centers6 papers (2018–2024)Gert J. de Borst · Surgical Specialties (Canada)5 papers (2020–2024)Hester M. den Ruijter · Utrecht University5 papers (2020–2024)Koen H.M. Prange · Amsterdam University Medical Centers5 papers (2020–2024)Lotte Slenders · Utrecht University4 papers (2020–2024)Arjan Boltjes · Princess Máxima Center4 papers (2020–2024)Michal Mokrý · Utrecht University4 papers (2020–2024) · 4 papers (2020–2023)Anton Jan van Zonneveld · Georgia Institute of Technology3 papers (2013–2023)J. Wouter Jukema · University of Palermo3 papers (2013–2023)Erik A.L. Biessen · New York University3 papers (2013–2023)Mete Civelek · Institute of Human Genetics3 papers (2021–2024)Sander W. van der Laan · Utrecht University3 papers (2020–2024)Dominique P.V. de Kleijn · Utrecht University3 papers (2021–2024)Saskia C.A. de Jager · University Medical Center Utrecht3 papers (2013–2020)Ilze Bot · Utrecht University3 papers (2013–2023)Bram Slütter · University of Iowa3 papers (2018–2023)Robin Hartman · AstraZeneca (Finland)2 papers (2023–2024)Adriaan O. Kraaijeveld · Utrecht University2 papers (2013–2023)